title: Vascular oxygen sensing: detection of novel candidates by proteomics and organ culture.
abstract: We have shown that the specific inhibition of hypoxia-induced relaxation by organ culture in porcine coronary arteries can be mimicked by treatment of control vessels with the protein synthesis inhibitor, cycloheximide. We hypothesize that organ culture of vascular smooth muscle results in the decreased expression of proteins that are critical for vascular oxygen sensing. Using two-dimensional gel electrophoresis and mass spectroscopy, we identified such candidate proteins. The expressions of the smooth muscle-specific protein, SM22, and tropomyosin are decreased after 24 h in organ culture. These results were confirmed by Western blot analysis. Other smooth muscle proteins (actin and calponin) exhibited little change. We also demonstrate a 50% downregulation in the small G protein, Rho, a potent modulator of Ca(2+)-independent force. These results indicate that organ culture preferentially inhibits the expression of certain smooth muscle proteins. This change in protein expression after organ culture correlates with the specific inhibition of hypoxic vasorelaxation. These results provide novel target pathways for investigation that are potentially important for vascular oxygen sensing.
authors.affiliation: Department of Molecular and Cellular Physiology, College of Medicine, University of Cincinnati, Ohio 45267-0576, USA. george.thorne@amedd.army.mil
authors.forename: George D
authors.initials: GD
authors.lastname: Thorne
authors.forename: George M
authors.initials: GM
authors.lastname: Hilliard
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Paul
mesh_terms: D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / Q000494:pharmacology; D000818:Animals; D019086:Bridged Bicyclo Compounds, Heterocyclic; D003331:Coronary Vessels / Q000502:physiology*; D015536:Down-Regulation; D015180:Electrophoresis, Gel, Two-Dimensional; D005231:Fatty Acids, Unsaturated; D006834:Hydrazines / Q000494:pharmacology; D000860:Hypoxia / Q000378:metabolism* / Q000503:physiopathology*; D008840:Microfilament Proteins / Q000378:metabolism; D009124:Muscle Proteins / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism; D009924:Organ Culture Techniques; D010100:Oxygen / Q000378:metabolism*; D040901:Proteomics; D013552:Swine; D014335:Tropomyosin / Q000378:metabolism; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D020741:rho GTP-Binding Proteins / Q000378:metabolism
chemical_list: D019086:Bridged Bicyclo Compounds, Heterocyclic; D005231:Fatty Acids, Unsaturated; D006834:Hydrazines; D008840:Microfilament Proteins; D009124:Muscle Proteins; D014335:Tropomyosin; D014662:Vasoconstrictor Agents; C051615:transgelin; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; C045749:SQ 29548; D020741:rho GTP-Binding Proteins; D010100:Oxygen